Research use only. This compound is supplied for in-vitro laboratory research by qualified researchers. It is not for human or veterinary consumption and has not been evaluated by the FDA.

Cellular & Redox
Pinealon
Certificate pending · 20mg
20mg$105.00each
$5.25/mg
Pinealon is a synthetic tripeptide, Glu-Asp-Arg, from the Khavinson short-peptide bioregulator programme. The programme is associated with the St Petersburg Institute of Bioregulation and Gerontology, and the literature also refers to this peptide by its three-letter code EDR.
The sequence is confirmed from three independent directions rather than from vendor copy, which for this class of compound is unreliable: the US patent application 2012/0309688A1 claims the peptide as H-Glu-Asp-Arg-OH, the NLM MeSH supplementary concept record C570174 gives Pinealon and glutamyl-aspartyl-arginine as entry terms for the same substance, and Khavinson's own 2021 review in Molecules lists EDR under this name.
Both termini are unmodified: a free N-terminal amine and a free C-terminal carboxyl. The formula and mass above are for that free acid, as registered at PubChem CID 10273502 and stated independently in the patent. The isolated substance described in the patent is an acetate ion pair, and no primary source states the acetate stoichiometry, so a mass quoted for the salt cannot be derived from the figure here.
There is no tryptophan, tyrosine or phenylalanine, which means there is no chromophore at 280 nm. The patent's own analysis reflects that: its chromatography is run at 220 nm, where the peptide bond absorbs, rather than at the wavelength an aromatic residue would provide. There is no cysteine and no methionine, so there is no oxidation-prone side chain at all.
Its molecular work is nucleic-acid binding rather than receptor binding, and no receptor has been identified. Fedoreyeva and colleagues, in Biochemistry (Moscow) in 2011, followed a fluorescently labelled peptide into the cytoplasm, nucleus and nucleolus of HeLa cells and measured Stern-Volmer quenching constants against labelled deoxyribooligonucleotides, reporting preferential binding to CAG-containing sequences and discrimination of cytosine methylation state. Silanteva and colleagues, in the Journal of Physical Chemistry B in 2019, used ultraviolet spectroscopy, NMR, viscosimetry and molecular dynamics to place the peptide partly inside the DNA major groove contacting the N7 and O6 atoms of guanine, with magnesium strengthening the interaction by screening phosphate charge.
It also appears in transporter docking work: Khavinson and colleagues, in Biomolecules in 2023, scored it as the best-ranked ligand of LAT1 and PEPT1 among twenty-six ultrashort peptides. That is a computational result and is stated as one.
Certificate pending for the 20mg lot.The signed report will be published here as soon as the laboratory returns it.
Ordering at volume or on a schedule?
Request a supply quote →Buy more of this strength and the price comes down. The store applies it at checkout - there is nothing to enter.
Free US shipping - no minimum
Tell us the lot number and what you observed. If independent testing shows a discrepancy against our published certificate, we refund the lot in full and pull it from sale pending investigation.
Tell us the lot number and what you observed. If independent testing shows a discrepancy against our published certificate, we refund the lot in full and pull it from sale pending investigation.
Certificate pending
Discreet packaging
Dispatched within one business day
Free US shipping, no minimum
Compound information
- Type
- Cellular & Redox
- CAS number
- 175175-23-2
- Molecular formula
- C15H26N6O8
- Molecular weight
- 418.40 g/mol
- Sequence
- Glu-Asp-Arg (EDR)
- Form
- Lyophilized powder
- Vial strength
- 20mg
- Catalogue number
- PX-PINE-20MG
- Purity
- Certificate pending for this strength
Identifiers are published properties of the molecule. Values we cannot confirm are omitted rather than estimated.
Research overview
A tripeptide of two acidic residues and one basic. Small enough to show every hydrogen.
- Residues
- 3
- Atoms
- 54
Primary literature
We have not compiled a reading list for this compound, and would rather show nothing than pad one out.
No public database record resolved for this compound under its catalogue name either. Rather than point you at a search that returns something else, this section stays empty.
PubMed, PubChem and ClinicalTrials.gov are independent scientific databases. A record or a published paper is not an endorsement of this product, and nothing indexed there describes an application, dose or outcome supported by PepXtide.
Storage & handling
Lyophilized
Store lyophilized at -20C, protected from light and moisture. The molecule has no cysteine, no methionine and no aromatic residue, so it carries none of the oxidation or photolysis liabilities that govern longer peptides, and hygroscopicity is the practical concern for the powder. No published stability study exists for this compound, so any working period should be established in the laboratory. Once in solution, keep refrigerated and prepare fresh..
Reconstituted
Refrigerate after reconstitution and use within the period appropriate to the material.
Safety & handling
Bench handling, not a dosing guide.
Intended use
Supplied strictly as a laboratory research material for in-vitro study by qualified researchers. Not for human or veterinary use, not for ingestion or injection, and not for any clinical or diagnostic application.
Personal protective equipment
Handle with gloves, eye protection and a laboratory coat. Weigh and transfer lyophilized powder in a ventilated enclosure to avoid generating an inhalable dust.
Reconstitution
Reconstitute against the diluent and volume appropriate to your protocol, adding solvent slowly down the vial wall rather than directly onto the pellet. Do not shake. This is a handling note, not a dosing guide.
Storage after opening
Once reconstituted, refrigerate and use within the period appropriate to the material. Avoid repeated freeze-thaw cycles, which degrade peptides faster than continuous storage at the listed temperature.
Disposal
Dispose of material and containers in accordance with your institution's chemical waste procedures and applicable local regulations.
Research notice
Supplied as a lyophilized powder for in-vitro laboratory research only. No statement on this page describes an application, benefit, dose, route or outcome. Descriptions are structural and mechanistic, and reference data such as CAS numbers and molecular formulas is published information about the compound itself, provided for identification. No measured result is shown for this strength because a certificate has not yet been published for its lot.

